Amgen (AMGN) Treasury Shares (2009 - 2025)

Amgen (AMGN) has reported Treasury Shares for 16 consecutive years, with $1.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares fell 65.71% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (down 65.71% YoY), while the FY2025 annual figure was $1.2 million, down 65.71% from the prior year.
• Treasury Shares came in at $1.2 million for Q4 2025 at Amgen, down from $3.5 million in the prior quarter.
• The five-year high for Treasury Shares was $26.1 million in Q4 2022, with the low at $1.2 million in Q4 2025.
• Average Treasury Shares over 4 years is $10.4 million, with a median of $4.6 million recorded in 2021.
• The largest YoY upside for Treasury Shares was 564.86% in 2022 against a maximum downside of 67.39% in 2022.
• Year by year, Treasury Shares stood at $21.7 million in 2021, then rose by 20.28% to $26.1 million in 2022, then plunged by 86.59% to $3.5 million in 2024, then plunged by 65.71% to $1.2 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.2 million, $3.5 million, and $26.1 million for Q4 2025, Q4 2024, and Q4 2022 respectively.